SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
291.20    5.80 (2.03%)
Bid:
291.00
Ask:
291.80
Spread: 0.80 (0.275%)
Market Cap: £1.01b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Director/PDMR Shareholding

28 Nov 2025 15:29

RNS Number : 5043J
Breedon Group PLC
28 November 2025
 

 

 

LEI: 213800DQGNQE3X76WS92

28 November 2025

 

BREEDON GROUP plc

(the Company)

 

Notification of transactions by Directors/Persons Discharging Managerial Responsibilities (PDMR) and Persons Closely Associated with them (PCA)

The Company has been notified that:

1. on 26 November 2025, Abicad Holding Limited (Abicad), a PCA of Amit Bhatia, Non-executive Chair of Breedon Group plc (Company) and PDMR, acquired 200,000 ordinary shares of £0.01 each in the Company (Shares) at the price of 369.6423 pence per Share upon the exercise of the fifth tranche of the option agreements entered into on 27 November 2024 (and notified to the market on 2 December 2024) (the Option Agreements); and

2. on 27 November 2025, Abicad acquired a further 200,000 Shares at the price of 392.7450 pence per Share upon the exercise of the sixth tranche of the Option Agreements.

Under the Option Agreements the relevant option tranche is automatically exercised and the relevant Shares are acquired if the closing price of a Breedon ordinary share is below or equal to the relevant exercise price for that tranche on the option expiration date.

Following the exercise of the first six tranches of the Option Agreements, Abicad currently holds 66,654,894 Shares, equating to approximately 19.23% of the Company's total issued share capital (at today's date). If all of the Shares are acquired under the remaining tranches of the Option Agreements and Abicad does not dispose of any of its existing interests in the Shares, Abicad would have an aggregate interest in 67,054,894 Shares, equating to approximately 19.34% of the Company's total issued share capital (at today's date).

The acquisitions of the Shares described above, and any potential future acquisitions, represent a continuation of Abicad's previously announced intention to make market purchases of the Shares over time. 

This notification is made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

Enquiries:

 

Breedon Group plc www.breedongroup.com 

James Atherton-Ham, Group General Counsel +44 (0)1332 981215

Louise Turner-Smith, Head of Investor Relations +44 (0)7860 911909

 

MHP (Public Relations Adviser) +44 (0)7770 753 544

Reg Hoare, Rachel Farrington, Charles Hirst breedon@mhpgroup.com

Notification and public disclosure of transactions by persons discharging managerial

responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Abicad Holding Limited, a person closely associated with Amit Bhatia

2

Reason for the notification

a)

Position/status

Non-executive Director and PDMR

b)

Is this an initial notification or an amendment to a prior notification?

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Breedon Group plc

b)

LEI

213800DQGNQE3X76WS92

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of £0.01 each

 

GB00BM8NFJ84

b)

Nature of the transaction

Purchase of Ordinary Shares pursuant to an option to acquire shares from a market counterparty

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£3.696423 per share

200,000

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

200,000

 

£3.696423

e)

Date of transaction

2025-11-26

f)

Place of the transaction

Outside a trading venue

 

 

Notification and public disclosure of transactions by persons discharging managerial

responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Abicad Holding Limited, a person closely associated with Amit Bhatia

2

Reason for the notification

a)

Position/status

Non-executive Director and PDMR

b)

Is this an initial notification or an amendment to a prior notification?

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Breedon Group plc

b)

LEI

213800DQGNQE3X76WS92

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of £0.01 each

 

GB00BM8NFJ84

b)

Nature of the transaction

Purchase of Ordinary Shares pursuant to an option to acquire shares from a market counterparty

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£3.927450 per share

200,000

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

200,000

 

£3.927450

e)

Date of transaction

2025-11-27

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFEIFIAEISEEF
Date   Source Headline
9th Jun 20267:00 amRNSAcquisition
13th May 20265:41 pmRNSDirector/PDMR Shareholding
12th May 20262:03 pmRNSHolding(s) in Company
30th Apr 20263:14 pmRNSTotal Voting Rights
29th Apr 20265:01 pmRNSResult of AGM
29th Apr 20267:00 amRNSAGM Trading Update
16th Apr 20264:40 pmRNSDirector/PDMR Shareholding
14th Apr 20265:10 pmRNSDirector/PDMR Shareholding
10th Apr 20269:55 amRNSHolding(s) in Company
9th Apr 20263:29 pmRNSDirector/PDMR Shareholding
9th Apr 20269:07 amRNSHolding(s) in Company
8th Apr 20263:41 pmRNSDirector/PDMR Shareholding
7th Apr 202612:00 pmRNSDirector/PDMR Shareholding
7th Apr 20269:48 amRNS-RBacking British Cement
31st Mar 20262:08 pmRNSTotal Voting Rights
24th Mar 20264:36 pmRNSHolding(s) in Company
23rd Mar 20262:05 pmRNSHolding(s) in Company
23rd Mar 20262:04 pmRNSHolding(s) in Company
23rd Mar 202612:01 pmRNS2025 Annual Report and Notice of AGM
19th Mar 20269:20 amRNSHolding(s) in Company
18th Mar 202610:41 amRNSHolding(s) in Company
16th Mar 202611:43 amRNSHolding(s) in Company
11th Mar 202611:39 amRNS-RBacking British Cement
11th Mar 20267:00 amRNSFinal Results
4th Mar 20267:00 amRNS-RLive presentation via Investor Meet Company
27th Feb 20269:33 amRNSTotal Voting Rights
11th Feb 20264:01 pmRNSIssue of Shares
30th Jan 202612:44 pmRNSBlock Listing Update
30th Jan 20267:00 amRNSNotice of Annual Results 2025
31st Dec 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
31st Dec 20257:00 amRNSTotal Voting Rights
2nd Dec 20253:49 pmRNSDirector/PDMR Shareholding
28th Nov 20253:29 pmRNSDirector/PDMR Shareholding
28th Nov 20258:55 amRNSTotal Voting Rights
26th Nov 20255:20 pmRNSDirector/PDMR Shareholding
21st Nov 20257:00 amRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSTrading Update
12th Nov 20253:30 pmRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSAppointment of Joint Corporate Broker
31st Oct 202510:43 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSTotal Voting Rights
29th Aug 20254:17 pmRNSTotal Voting Rights
29th Aug 20253:51 pmRNSHolding(s) in Company
29th Aug 20253:46 pmRNSHolding(s) in Company
29th Aug 202512:18 pmRNSDirector/PDMR Shareholding
13th Aug 202511:13 amRNSDirector/PDMR Shareholding
31st Jul 20258:51 amRNSTotal Voting Rights
24th Jul 202510:03 amRNSDirector/PDMR Shareholding
24th Jul 202510:02 amRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSInterim Results 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.